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Depression is associated with elevated kynurenine levels, a tryptophan metabolite generated under stress
and inflammatory conditions. Agudelo et al. (2014) now reveal how PGC-1a1 overexpression in muscle
mimics anti-depressant effects of exercise by promoting kynurenine aminotransferase expression, likely pre-
venting kynurenine from crossing the blood brain barrier to disrupt neural plasticity.Exercise has many health benefits for
body andmind. Physical activity improves
cognition and reduces mood disorders
(Lawlor and Hopker, 2001). Research
into underlying mechanisms has focused
on central changes in neurotransmission,
neurogenesis, growth factors, and blood
flow. Less attention has been given to
peripheral factors that may affect brain
function during exercise. In particular,
activation of skeletal muscle may play an
important role. This has become particu-
larly relevant with the identification of
muscle fiber contractile and metabolic
genes, which can be activated by exer-
cise, pharmacological agents, and the
overexpression of selected transcription
factors. Specifically, peroxisome prolifer-
ator-activated receptor-gamma co-acti-
vator (PGC)-1a1 regulates fatty acid
oxidation, gluconeogenesis, muscle fiber
composition, and mitochondrial biogen-
esis. Exercise increases expression of
PGC-1a1 in muscle and liver in rodents
and humans (Arany, 2008). PGC-1a1
(and PPARa/d) is controlled by the AMP-
activated protein kinase (AMPK), amaster
metabolic regulator important for glucose
homeostasis, appetite, and exercise
physiology (Smith et al., 2013). AMPK
activation enhances running endurance
in sedentary mice (Narkar et al., 2008).
Interestingly, brain plasticity and memory
function is enhanced by administration of
AMPK and PPARd agonists in wild-type
(WT) mice, but not in skeletal muscle-spe-
cific AMPK mutant mice (Kobilo et al.,
2011, 2014). These studies indicate that
skeletal muscle secretes factors that in-
fluence the brain and behavior in
response to physiological demands. Agu-
delo et al. (2014) now reveal a metabolic
pathway linking skeletal muscle and the
brain to regulate depression.560 Cell Metabolism 20, October 7, 2014 ª20Agudelo and colleagues exposed mice
that overexpress PGC-1a1 in muscle
(mck-PGC-1a1) to a 5-week-long chronic
mild unpredictable stress (CMS) protocol,
which causes a depression-like pheno-
type in rodents. They found that mck-
PGC-1a1 mice are resistant to stress,
as evidenced by a lack of change in
behavioral assays relevant to depression,
such as the forced swim and sucrose
preference tests. Concurrently, expres-
sion of hippocampal synaptic plasticity
related genes, such as calcium-calmod-
ulin-dependent protein kinase (CamkII),
activity-regulated cytoskeleton-associ-
ated protein (ARC), and brain-derived
neurotrophic factor (BDNF), was unaf-
fected by CMS in transgenic as
compared to WT mice. In addition, mck-
PGC-1a1 mice are protected from pro-
inflammatory changes that can trigger
depressive disorders. Specifically, cyto-
kines typically induced by CMS such as
IL-6, TNFa, and IL-1b were unchanged
in mck-PGC-1a1 mouse hippocampus,
while IL-10, an anti-inflammatory cyto-
kine, was significantly increased. Fur-
thermore, the CMS-driven increase in
hypothalamic corticotrophin-releasing
hormones was attenuated in mck-PGC-
1a1 mice. The resilience of mck-PGC-
1a1 mice to depression may be due in
part to amelioration of stress-induced
neuro-inflammation.
To explore mechanisms underlying
muscle-brain communication, Agudelo
et al. (2014) conducted gene-expression
analysis, which showed elevated levels
of kynurenine amino transferases (KAT)
1, 3, and 4 in the muscle of mck-PGC-
1a1 mice. Kynurenine (KYN) is a
metabolite of tryptophan converted into
kynurenic acid (KYNA) by KAT enzymes.
The KYN pathway is considered impor-14 Elsevier Inc.tant for depression (Schwarcz et al.,
2012). In fact, the expression level of
several rate-limiting enzymes in the KYN
pathway was increased by CMS in WT
(Figure 1A) but not in mck-PGC-1a1
mice (Figure 1B). Moreover, plasma KYN
levels were unchanged, while plasma
KYNA levels were higher in the transgenic
mice. However, these alterations of the
KYN pathway did not affect total plasma
or brain tryptophan and serotonin levels
or its metabolites, suggesting that trypto-
phan metabolism changes specifically
within muscle. The authors also showed
that administration of exogenous KYN
reduced sucrose consumption in WT but
not in mck-PGC-1a1 mice, providing
further evidence that the transgenic
mice are resistant to depression. Fur-
thermore, KYN treatment in WT mice re-
sulted in brain gene-expression patterns
similar to that of the pro-inflammatory,
KYN pathway, with reduced expression
of synaptic plasticity genes, including
immediate early gene ARC and AMPA re-
ceptor subunit GluA2. Consistently, mice
with skeletal muscle-specific PGC-1a1
deletion had reduced KAT expression
levels in muscle and displayed depres-
sive behavior (anhedonia) following KYN
administration.
To further understand the regulation of
KAT expression, the authors analyzed
the direct repeat 1 (DR1) sequence, an
element located in the genomic region
surrounding the KAT1, 3, and 4 genes
that is recognized by PPAR a and d.
They showed that an association be-
tween PGC-1a1 and PPAR a/d con-
trols KAT expression in the myotube.
Additionally, 8 weeks of voluntary wheel
running increased skeletal muscle KAT
1, 3, and 4 and plasma KYNA levels
in WT mice (Figure 1C). Consistently, a
Figure 1. Schematic of the Role ofMuscle-Specific (mck)-PGC-1a1Overexpression in aMouseModel of Depression Caused byChronicMild
Stress
(A) Plasma kynurenine (KYN) levels are elevated by chronic mild stress (top) in wild-type (WT) mice. KYN crosses the blood-brain barrier (middle panel) and re-
duces neuronal plasticity by increasing neuro-inflammation (bottom)—and, in turn, causes depression-like behaviors.
(B) Activation of the skeletal muscle AMPK - PGC-1a1 pathway influences secretion of proteins involved in muscle adaptation. Agudelo et al. show that mck-
PGC-1a1 mice are protected from exhibiting depressive-like behavior induced by chronic mild stress through upregulation of the PPARa/d-KAT-Kynurenine
pathway.
(C) The discovery of a novel paracrine mechanism mediating communication between skeletal muscle and brain may provide insight into the beneficial effects of
exercise on cognition and mood. Future studies may lead to identification of key molecules for brain function, induced by muscle PGC-1a1 overexpression or
AMPK activation during exercise.
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elevated skeletal muscle KAT 1-4 expres-
sion. Altogether, these findings suggest
that skeletal muscle PGC-1a1 plays an
important role in regulation of muscle
KAT enzyme expression, which modu-
lates plasma KYN levels to, in turn, influ-
ence hippocampal neuronal plasticity
and to alleviate stress-induced depres-
sion. This novel function of PGC-1a1 in
regulation of the KYN pathway further
substantiates the concept of communi-
cation between skeletal muscle and
brain.
This research raises further questions.
On a systemic level, elevated PGC-1a1
in muscle improves insulin metabolism,
which may convey antidepressant-likeeffects (Oxenkrug, 2013). In addition, the
role of muscle in brain function could be
explored further. For example, uptake
of tryptophan and its metabolites into
muscles of the transgenic mice could be
measured. This is important because
total plasma tryptophan levels were un-
changed in mck-PGC-1a1 mice after
CMS, raising the possibility that higher
levels of tryptophan within muscle lead
to elevated efflux of KYNA. In addition,
to further evaluate whether there is
a causal connection between muscle
PGC-1a1 and depression, it would be
interesting to examine whether muscle
specific deletion of PGC-1a1 or KAT
abolishes the antidepressant effect of
exercise. Furthermore, PGC-1a1 proteinCell Metabolism 2measurement in the muscles of stressed
WT mice and mood disorder patients
may give additional insight into depres-
sion etiology. Finally, the brains of
mck-PGC-1a1 mice warrant a closer
examination. Genes and proteins impor-
tant for glutamatergic neurotransmission
(Hashimoto, 2009) such as AMPA recep-
tors, CamKII, and glial fibrillary acidic
protein (GFAP) are upregulated in the
transgenic mice at baseline, without
CMS. These neural changes could
modify brain structure, size, neuronal
number, and function. In addition, hippo-
campal synaptic physiology, adult neuro-
genesis, and memory function (Kobilo
et al., 2011) may be affected by PGC-
1a1 overexpression in skeletal muscle.0, October 7, 2014 ª2014 Elsevier Inc. 561
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burden on society (Lawlor and Hopker,
2001). The study by Agudela et al. demon-
strates that skeletal muscle PGC-1a1
overexpression can counteract depres-
sion and acts as an exercise-mimetic that
modulates paracrine factors. Understand-
ing the mechanisms underlying muscle-
to-brain communication may open up
avenues to new therapeutic approaches.
Indeed, it will be important to identify the
key proteins and metabolites that are
dynamically secreted by muscle during
exercise to meet the brain’s physiological
demands. In the future, these may lead to
treatments for a variety of brain disorders,
including psychiatric and cognitive con-
ditions as well as neurodegenerative
diseases.562 Cell Metabolism 20, October 7, 2014 ª20ACKNOWLEDGMENTS
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Periostin is a crucial extracellular remodeling factor in the inflammatory and tumormicroenvironments, but its
function in nonalcoholic fatty liver disease remains unclear. Lu et al. (2014) now demonstrate that periostin is
a critical player in the regulation of hepatic triglyceride homeostasis and the development of obesity-induced
hepatosteatosis.Nonalcoholic fatty liver disease (NAFLD),
one of the most prevalent causes of
chronic liver disease in the Western
world, refers to a clinical metabolic syn-
drome with excessive fat deposition in
the liver not due to alcohol abuse. NAFLD
ranges from simple steatosis to nonalco-
holic steatohepatitis (NASH); the latter in-
cludes and leads to progressive fibrosis
and hepatocellular carcinoma (HCC).
Aberrant triglyceride (TG) accumulation
in hepatocytes is recognized as the hall-
mark of NAFLD. This dysregulated TG
accumulation is closely related to obesity
and metabolic syndrome (Cohen et al.,
2011; Michelotti et al., 2013). In humans,
obesity is strongly associated with hepa-tosteatosis and NASH pathogenesis
(Umemura et al., 2014); however, the
development and progression of hepa-
tosteatosis and steatohepatitis as well
as the mechanisms underlying obesity-
induced fatty liver remain poorly under-
stood. A recent intriguing article in the
Journal of Clinical Investigation demon-
strates that periostin (encoded by Postn)
mediates obesity-induced hepatosteato-
sis (Lu et al., 2014).
To identify genes involved in aberrant
hepatic lipid homeostasis in obesity, Lu
et al. (2014) performed a clustering anal-
ysis of Affymetrix arrays and found that
periostin expression is markedly elevated
in the liver of high-fat-diet-fed mice. Thisphenotype was also observed in ob/ob
and db/db obese mice, as well as in
NAFLD patients, indicating that periostin
overproduction in the liver is a conserved
phenotype in both obese rodents and
humans. Interestingly, hepatic periostin
expression was induced by high glucose
via the transcription factor ChREBP, and
overexpression of periostin in the liver of
C57BL/6 mice resulted in hepatic TG
accumulation and increased liver weight.
Similar results were obtained by treating
HepG2 cells and mouse primary hepato-
cytes (MPHs) with recombinant periostin
protein. These data suggest that perios-
tin promotes TG accumulation in the
liver.
